2Corrales JJ, Orfao A, Lopez A, et al. CD5^+ B cells in Graves' disease : correlation with disease activity. Horm Metab Res, 1996,28:280-285.
3Corrales JJ, Orfao A, Lopez A, et al. Serial analysis of the effects of methimazole therapy on circulating B cell subsets in Graves' disease. J Endocrinol, 1996,151:231-240.
4Paggi A, Amoroso A, Ferri GM, et al. Methimazole treatment in Graves disease: behaviour of CD5^+ B lymphocytes and regulatory T cell subsets.Eur Rev Med Pharmacol Sci, 1998,2:11-19.
5Nagayama Y.Animal models of Graves,hyperthyroidism,Endocrinol J.2005,52:385.
6Modi J,Patel A,Terrell R,et al.Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes.J Clin Endocrinol Metab,2003,88:4418.
7Fujimotoa M,Sato S.B lymphocytes and systemic sclerosis.Curr Opin Rheumatol,2005,17:746.
8Corrales JJ,Lopez A,Ciudad J,et al.Methimazole therapy in Graves'disease influences the abnormal expression of CD69(early activation antigen)on T cells.J Endocrinol,1997,155:491.
9Roura-Mir C,Catalfamo M,Sospedra M,et al.Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto'S and Graves'diseases.Eur J Immunol,1997,27:3290.
10Artur B,Mlroslawa U,and Anna S B.Analysis of Circulating T γ/δ Lymphocytes and CD1656 Cell Populations in Children and Adolescents with Graves ' Disease.Pediatr Res 2003,54:425.
